Joseph S. Dosch

c-Met Is a Marker of Pancreatic Cancer Stem Cells and Therapeutic Target

Chenwei Li, Jingjiang Wu, Mark J. Hynes et al. · Gastroenterology · 2011 · 387 citations

Medicine, Cancer Biology, Oncology +14

Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy That Cotargets MEK and CDK4/6

Elizabeth K. Ziemke, Joseph S. Dosch, Joel D. Maust et al. · Clinical Cancer Research · 2015 · 96 citations · Full text

Medicine, Oncology, Pharmacology +17

The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling

Shyam Nyati, Katrina Schinske-Sebolt, Sethuramasundaram Pitchiaya et al. · Science Signaling · 2015 · 94 citations

Life Sciences, Cell Biology, Molecular Biology +10

Targeting ADAM17 inhibits human colorectal adenocarcinoma progression and tumor-initiating cell frequency

Joseph S. Dosch, Elizabeth K. Ziemke, Shanshan Wan et al. · Oncotarget · 2017 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Modeling Selective Elimination of Quiescent Cancer Cells from Bone Marrow

Stephen P. Cavnar, Andrew D. Rickelmann, Kaille F. Meguiar et al. · Neoplasia · 2015 · 38 citations · Full text

Medicine, Cancer Biology, Oncology +17